BridgeBio Oncology Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
BridgeBio Oncology Therapeutics, Inc. (BBOT) had Common Stock, Capital Shares Reserved for Future Issuance of 16.39 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 16.39M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 16.62M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 11.44M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 43.01M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 16.39M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 16.62M shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 11.44M shares 10-Q · filed 2026-08-11 |
| 2024-12-31 | 43.01M shares POS AM · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |